MR-107A-01

· Mylan Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MR-107A-01, covering 2022-08-08 to 2022-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain [Phase 2]